TrialBreast cancer research and treatment2025

A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer.

Nan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.